OpGen, Inc. is a microbial genetics analysis company. The Company offers optical mapping services for analysis of microbial, yeast and fungal genomic architecture. OpGen, Inc. headquartered in Gaithersburg, Maryland.
Revenue (Most Recent Fiscal Year) | $2.61M |
Net Income (Most Recent Fiscal Year) | $-37.28M |
PE Ratio (Current Year Earnings Estimate) | -- |
PE Ratio (Trailing 12 Months) | -- |
PEG Ratio (Long Term Growth Estimate) | -- |
Price to Sales Ratio (Trailing 12 Months) | 2.32 |
Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 2.11 |
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
Pre-Tax Margin (Trailing 12 Months) | -852.18% |
Net Margin (Trailing 12 Months) | -852.18% |
Return on Equity (Trailing 12 Months) | -316.30% |
Return on Assets (Trailing 12 Months) | -89.52% |
Current Ratio (Most Recent Fiscal Quarter) | 0.28 |
Quick Ratio (Most Recent Fiscal Quarter) | 0.18 |
Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
Inventory Turnover (Trailing 12 Months) | 1.96 |
Book Value per Share (Most Recent Fiscal Quarter) | $2.61 |
Earnings per Share (Most Recent Fiscal Quarter) | -- |
Earnings per Share (Most Recent Fiscal Year) | $-10.21 |
Diluted Earnings per Share (Trailing 12 Months) | $-6.51 |
Exchange | NASDAQ |
Sector | Healthcare |
Industry | Medical Devices |
Common Shares Outstanding | 12.62M |
Free Float | 12.46M |
Market Capitalization | $7.11M |
Average Volume (Last 20 Days) | 0.62M |
Beta (Past 60 Months) | -0.71 |
Percentage Held By Insiders (Latest Annual Proxy Report) | 1.33% |
Percentage Held By Institutions (Latest 13F Reports) | 2.68% |
Annual Dividend (Based on Last Quarter) | $0.00 |
Dividend Yield (Based on Last Quarter) | 0.00% |